Edition:
India

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

17.77USD
23 Aug 2019
Change (% chg)

$-0.35 (-1.93%)
Prev Close
$18.12
Open
$18.02
Day's High
$18.06
Day's Low
$17.45
Volume
60,741
Avg. Vol
66,207
52-wk High
$24.70
52-wk Low
$10.25

Latest Key Developments (Source: Significant Developments)

Accelerate Diagnostics says On Aug 20, Co And Entity Affiliated With Phillips Entered Into Securities Purchase Agreement
Thursday, 22 Aug 2019 

Aug 21 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS INC - ON AUG 20, CO AND ENTITY AFFILIATED WITH PHILLIPS ENTERED INTO SECURITIES PURCHASE AGREEMENT.ACCELERATE DIAGNOSTICS INC - PURCHASE AGREEMENT FOR ISSUANCE, SALE BY CO OF AGGREGATE OF 55,586 SHARES OF CO'S COMMON STOCK IN OFFERING.ACCELERATE DIAGNOSTICS - SHARES WERE SOLD AT PURCHASE PRICE OF $17.99 PER SHARE.  Full Article

Accelerate Diagnostics Q4 Loss Per Share $0.41
Wednesday, 20 Feb 2019 

Feb 19 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS 2018 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.41.Q4 SALES $1.8 MILLION VERSUS $2.1 MILLION.Q4 REVENUE ESTIMATE $2.6 MILLION -- REFINITIV IBES DATA.Q4 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.  Full Article

Accelerate Diagnostics Sees Q4 Revenue About $1.8 Mln
Monday, 7 Jan 2019 

Jan 6 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS ANNOUNCES PRELIMINARY 2018 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS.SEES Q4 REVENUE ABOUT $1.8 MILLION.SEES FY 2018 REVENUE $5.7 MILLION.ACCELERATE DIAGNOSTICS - NET CASH USED, EXCLUDING FINANCING, IS EXPECTED TO BE APPROXIMATELY $14.1 MILLION FOR Q4 AND $64.1 MILLION FOR FULL-YEAR 2018.  Full Article

Accelerate Diagnostics Inc Quarterly Net Loss Per Share $0.43
Tuesday, 7 Aug 2018 

Aug 6 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS Q2 2018 FINANCIAL RESULTS.Q2 REVENUE $1.7 MILLION.Q2 REVENUE VIEW $2.1 MILLION -- THOMSON REUTERS I/B/E/S.QUARTERLY NET LOSS PER SHARE $0.43.  Full Article

Accelerate Diagnostics reports Q3 loss per share $0.31
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics Inc reports q3 2017 financial results.Q3 loss per share $0.31.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.  Full Article